Phoenix Financial’s Exact Sciences EXAS Stock Holding History

Phoenix Financial’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,938	Closed	-$240K	–	336
2021 Q1	$240K	Buy	+1,938	New	+$265K	0.01%	365

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Phoenix Financial's EXAS Position: Q2 2021 in Review

Phoenix Financial sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 1,938 shares — an estimated $240K sold.

Phoenix Financial first reported a position in EXAS in Q1 2021 and held it in 1 quarter. The position peaked at $240K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

Phoenix Financial reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
Phoenix Financial sold 1,938 Exact Sciences shares in Q2 2021, an estimated $240K.
Phoenix Financial first reported a position in Exact Sciences in Q1 2021 and held it in 1 quarter.
Phoenix Financial's Exact Sciences position peaked at $240K in Q1 2021.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Phoenix Financial's 13F filing for Q2 2021, filed 10 Aug 2021.